Equifax (NYSE:EFX) Sets New 1-Year Low – What’s Next?

Equifax, Inc. (NYSE:EFX) hit a new 52-week low on Thursday . The company traded as low as $166.02 and last traded at $180.18, with a volume of 4896854 shares. The stock had previously closed at $175.05.

Equifax News Roundup

Here are the key news stories impacting Equifax this week:

• Positive Sentiment: Q4 beat — Equifax reported $2.09 EPS (vs. ~$2.05 cons.) and revenue of $1.551B, up ~9% year-over-year and roughly $30M above the midpoint of guidance, signaling stronger-than-expected demand in Workforce and USIS. Equifax Delivers Fourth Quarter 2025 Revenue Growth of 9%…
• Positive Sentiment: Product/tech tailwinds — Management highlighted that AI and the Equifax Cloud drove record-high product innovation and operational efficiencies in 2025, which supports higher-margin product growth over time. Equifax Says AI Tools Help Drive New Product Innovation to Record High
• Positive Sentiment: Partnership expansion — Equifax expanded a consumer-finance partnership with Gen to broaden solutions across consumers’ financial lives (potential revenue/penetration benefits). Gen and Equifax Expand Partnership to Deliver Comprehensive Solutions…
• Positive Sentiment: Analyst support — Morgan Stanley reiterated a Buy rating, citing a rebound in government business and long-term earnings power despite trimming the price target, which can bolster investor confidence. Equifax: Strong Q4 Beat…Support Buy Rating
• Neutral Sentiment: FY guidance roughly in line — Equifax set FY26 EPS guidance of $8.30–$8.70 and revenue $6.7–6.8B, broadly consistent with consensus, leaving full-year upside limited unless execution accelerates. Equifax projects 2026 profit above estimates after quarterly results beat
• Negative Sentiment: Cautious Q1 guide — Equifax guided Q1 EPS to $1.63–$1.73, below the street (~$1.78), which introduces short-term downside risk and was cited as a reason for lower near-term sentiment. Equifax Q4 Earnings Beat Estimates, Revenues Jump 9% Y/Y
• Negative Sentiment: Regulatory/political risk — Senators accused Equifax of “price‑gouging” Medicaid programs as states prepare to comply with new work requirements; that political scrutiny could create reputational, contractual or pricing pressure for government business. Senators Accuse Equifax of ‘Price-Gouging’ Medicaid Programs

Analyst Upgrades and Downgrades

EFX has been the subject of a number of research reports. BMO Capital Markets lowered their price target on shares of Equifax from $245.00 to $234.00 and set a “market perform” rating for the company in a report on Monday, December 8th. Wells Fargo & Company lowered their target price on Equifax from $285.00 to $265.00 and set an “overweight” rating for the company in a research note on Wednesday, January 14th. Needham & Company LLC restated a “buy” rating and set a $295.00 target price on shares of Equifax in a research report on Tuesday, October 21st. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Equifax in a research note on Monday, December 29th. Finally, Oppenheimer lowered their price objective on Equifax from $271.00 to $266.00 and set an “outperform” rating for the company in a research report on Monday, January 12th. One research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $268.57.

Equifax Stock Performance

The stock has a market cap of $22.05 billion, a P/E ratio of 34.19, a PEG ratio of 1.78 and a beta of 1.55. The stock has a fifty day simple moving average of $213.55 and a 200-day simple moving average of $228.29. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.82.

Equifax (NYSE:EFX) last announced its quarterly earnings results on Wednesday, February 4th. The credit services provider reported $2.09 earnings per share for the quarter, beating analysts’ consensus estimates of $2.05 by $0.04. Equifax had a net margin of 11.08% and a return on equity of 19.28%. The business had revenue of $1.55 billion for the quarter, compared to the consensus estimate of $1.53 billion. During the same period last year, the company posted $2.12 EPS. Equifax’s revenue for the quarter was up 9.3% on a year-over-year basis. Equifax has set its FY 2026 guidance at 8.300-8.700 EPS and its Q1 2026 guidance at 1.630-1.730 EPS. Equities analysts expect that Equifax, Inc. will post 7.58 earnings per share for the current fiscal year.

Institutional Trading of Equifax

A number of large investors have recently made changes to their positions in the company. Vanguard Group Inc. grew its stake in Equifax by 2.1% in the third quarter. Vanguard Group Inc. now owns 15,282,951 shares of the credit services provider’s stock valued at $3,920,535,000 after acquiring an additional 316,048 shares during the period. State Street Corp lifted its holdings in shares of Equifax by 0.4% during the 3rd quarter. State Street Corp now owns 4,990,152 shares of the credit services provider’s stock valued at $1,280,124,000 after purchasing an additional 21,255 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its holdings in shares of Equifax by 35.8% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 4,344,531 shares of the credit services provider’s stock valued at $942,676,000 after purchasing an additional 1,145,921 shares in the last quarter. Geode Capital Management LLC grew its position in shares of Equifax by 2.5% in the 2nd quarter. Geode Capital Management LLC now owns 3,142,763 shares of the credit services provider’s stock valued at $811,650,000 after purchasing an additional 75,627 shares during the period. Finally, Generation Investment Management LLP increased its stake in Equifax by 6.3% during the 3rd quarter. Generation Investment Management LLP now owns 2,736,467 shares of the credit services provider’s stock worth $701,986,000 after purchasing an additional 163,375 shares in the last quarter. Institutional investors own 96.20% of the company’s stock.

About Equifax

Equifax Inc (NYSE: EFX) is a global data, analytics and technology company that specializes in consumer and commercial credit reporting, decisioning tools and identity solutions. Headquartered in Atlanta, Georgia, Equifax is one of the three major consumer credit reporting agencies in the United States and provides credit information and related services to lenders, employers, governments and consumers worldwide.

The company’s offerings include consumer credit reports and scores, credit monitoring and identity protection services, and a range of business-oriented products for risk management, fraud detection and compliance.